
Global DTC Genetic Testing Market to Top $1.9B by 2026
Even when accounting for the impact of COVID-19, recent report suggests the future of direct-to-consumer genetic testing remains bright.
Even when accounting for the impact of COVID-19, recent report suggests the future of direct-to-consumer genetic testing remains bright.
Guidelines on use of genetic testing for inherited cardiovascular diseases have been revised in accordance with 2022 testing technology.
With increasing media coverage about problems with genetic non-invasive prenatal screening, the agency warns of risks of false results.
Collaboration between several key pharmaceutical companies looks to remove barriers for cancer patients to improve treatment selection.